Noveome Biotherapeutics hires operations SVP

Noveome Biotherapeutics Inc, a clinical-stage biopharmaceutical company, has named Kevin E. McCracken as senior vice president of operations. Recently, McCracken worked at Kadmon Pharmaceuticals where he was vice president of chemistry. Noveome's backers include Lancet Capital, UPMC Health System, Highmark Health, University of Pittsburgh and Carnegie Mellon University.

PeopleNorth AmericaUSHealthcareBriefs